Background: Chronic and treatment-resistant depressions pose serious problems in mental health care. Mindfulness-based cognitive therapy (MBCT) is an effective treatment for remitted and currently depressed patients. It is, however, unknown whether MBCT is effective for chronic, treatment-resistant depressed patients.
INTRODUCTION
Major depressive disorder is one of the leading causes of disability worldwide (Lopez, Mathers, Ezzati, Jamison, & Murray, 2006) . Despite evidence-based treatments, about 20% of all depressed patients develop a chronic course (Kessler et al., 2003) , typically defined as a period of 2 years or longer of depressive symptoms (DSM-IV-TR, This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. 2000). Chronic depression not only affects the personal life of a patient, but is also associated with high costs for society in terms of health care costs and workplace losses (Pincus, 2001) . Unfortunately, a large number of chronically depressed patients do not respond to treatment (Torpey & Klein, 2008) . Therefore, novel treatment strategies for this severely ill population are much needed (Cuijpers, Huibers, & Furukawa, 2017) . Surprisingly, no unified definition of treatment-resistant depression exists. Staging methods to measure treatment resistance mostly focus on the number of biological treatment steps (Trevino, McClintock, Fischer, Vora, & Husain, 2014) . In line with these staging methods, most clinical trials define a depressive episode as treatment-resistant if two or more trials with antidepressant medication were unsuccessful (Rush, Thase, & Dubé, 2003; Trevino et al., 2014) . However, this definition conflicts with multidisciplinary treatment guidelines (NICE, 2009 ), which state that depressed patients with moderate to severe symptoms should receive a combination of psychological and pharmacological treatments. Therefore, a new staging method to measure treatment resistance was developed, which is termed as the "Dutch Measure for quantification of Treatment Resistance in Depression" (DM-TRD) (Peeters et al., 2016) . In contrast to previous staging methods (Fekadu, Wooderson, Donaldson, et al., 2009; Petersen et al., 2005; Souery et al., 1999; Thase & Rush, 1997) , the DM-TRD not only focuses on biological treatments but also includes evidence-based psychological treatments. For these reasons, we have chosen to apply the criteria of the DM-TRD for treatment resistance in the current study.
Mindfulness-based cognitive therapy (MBCT) is an 8-week group training that combines mindfulness meditation techniques with elements of cognitive-behavioral therapy (Segal, Williams, & Teasdale, 2012) . MBCT teaches participants to recognize and disengage from maladaptive automatic cognitive patterns, and to develop a nonjudgmental and compassionate attitude toward their own cognitions and feelings. MBCT has been demonstrated to be effective in reducing relapse (Kuyken et al., 2016) . In addition, it has been shown that MBCT reduces depressive symptoms in currently depressed patients (Strauss, Cavanagh, Oliver, & Pettman, 2014) . Preliminary studies (Barnhofer Crane, Hargus, Amarasinghe, Winder, & Williams, 2009; Eisendrath et al., 2008; Kenny & Williams, 2007) have even found beneficial effects of MBCT for patients with chronic or treatmentresistant depression. In line with these findings, in a recent randomized controlled trial (RCT) of Eisendrath et al. (2016) in treatmentresistant depressed patients, MBCT was demonstrated to be superior to an active control group matched on treatment intensity. However, partly contrasting results were found by Michalak, Probst, Heidenreich, Bissantz, and Schramm (2016) in an RCT comparing MBCT with Cognitive Behavioural Analysis System of Psychotherapy (CBASP) and treatment-as-usual (TAU) in chronically depressed patients. CBASP is a psychological treatment with a strong interpersonal orientation that focuses on overcoming the learned helplessness of the patient by teaching patients that their own behavior affects others and themselves (McCullough, 2003) . Michalak et al. (2016) concluded that MBCT was inferior to CBASP, and MBCT was superior to TAU only at one treatment site.
Importantly, all available controlled studies about MBCT for treatment-resistant depression focused on pharmacoresistant depressed patients (Eisendrath et al., 2008 (Eisendrath et al., , 2016 . It therefore remains unclear whether MBCT is effective in chronically depressed patients who have been treated according to treatment guidelines (i.e., received evidence-based psychological treatment and pharmacotherapy) but have not responded.
The aim of the current study was to investigate the effectiveness of MBCT + TAU versus TAU only for chronically depressed patients with current moderate to severe depressive symptoms who have not responded to previous pharmacotherapy and evidenced-based psychological treatments, that is, cognitive behavioral therapy (CBT) or interpersonal therapy (IPT). The primary outcome measure was the level of depressive symptoms. Secondary outcome measures were remission rates, rumination, quality of life, mindfulness skills, and self-compassion. Additionally, we examined the following variables as potential moderators of treatment effect gender, age, childhood trauma, number of previous episodes, duration of current depressive episode, treatment resistance, baseline levels of depressive symptoms, rumination, mindfulness skills, and self-compassion.
METHOD

Design
This trial was an open-labeled, multicenter RCT comparing two groups:
MBCT + TAU and TAU. Methods and procedures are fully described in the published protocol (Cladder-Micus et al., 2015) and are summarized below. All participants gave written informed consent and the study was approved by the Medical Ethical Committee ArnhemNijmegen (number 2012/339).
Participants
Participants (N = 106) were recruited at different locations of a local mental health institute (Pro Persona) and a university medical center (Radboud University Medical Center, Centre for Mindfulness). Participants were referred by mental health care professionals or recruited via flyers, posters, and websites. Clinicians were also explicitly asked to screen their caseload for potentially eligible participants. A depressive episode was defined as "chronic" if symptoms persisted for ≥12 months, because research has shown that chances of recovery decrease substantially after this period (Spijker et al., 2002) . Inclusion criteria were (a) age ≥ 18, (b) current depressive episode according to DSM-IV criteria with a duration of ≥12 months, training. Baseline characteristics can be found in Table 1 . 
Procedure
Interested patients received an information letter and were contacted via telephone. During a subsequent research interview, the Mini International Neuropsychiatric Interview (MINI, Sheehan et al., 1998) 
Interventions
MBCT + TAU
MBCT was based on the manual by Segal, Williams, and Teasdale (2002) and consisted of 8 weekly 2.5-hr sessions and 1 day of practice (day of silence). Participants were enrolled in MBCT courses that were part of the regular treatment program for patients with depressive disorders. The average number of study participants was 2.41
(SD = 1.55) per MBCT group of 8-12 patients. Mindfulness trainers were informed about enrollment of participants in the study, but were pressed to adopt an identical approach and procedure for all patients. Group members were not informed about study participation of individual fellow members, but participants were of course allowed to share this information at will. All mindfulness trainers were highly experienced in working with depressed patients and had completed a postgraduate 2-year mindfulness teacher training. Thereby they met the advanced criteria of good practice guidelines of the UK Network for Mindfulness-Based Teachers (Network, 2011) . Teacher competence and adherence was assessed with the Mindfulness-Based
Interventions-Teaching Assessment Criteria (Crane et al., 2012 ) based on two video recorded sessions per trainer. Two independent mindfulness trainers rated the trainers. Mutually agreed ratings of the trainers were "proficient" (n = 2), "proficient/competent" (n = 1), "competent" (n = 2), and "advanced beginner" (n = 1). Videos of two trainers (who trained, respectively, two and three participants) were unavailable. Participants received TAU in conjunction with MBCT.
TAU
Treatment-as-usualTAU was a naturalistic condition consisting of mental health care for depression, including antidepressant medication, psychological treatment, support by a psychiatric nurse, or dayhospital treatment. There were no significant differences between conditions in the mean number of treatment sessions or in the number of patients who received these treatments (see Table 2 ). Medication levels at baseline can be found in Table 1 . A minority of participants changed in medication level. This information is summarized in Table 2 and additional information can be found in the Supporting Information Table 1 .
Outcome measures 2.5.1 Primary outcome measure
The primary outcome was the level of depressive symptoms assessed with IDS-SR (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) . The IDS-SR has good psychometric properties (Rush et al., 1996) . The IDS-SR has previously been used in research on MBCT and is sensitive to change (Geschwind, Peeters, Huibers, van Os, & Wichers, 2012) . In the current sample, the internal consistency was = 0.74.
Secondary outcome measures
Remission was assessed with the depression module of the MINI, Quality of life was assessed with the World Health Organization Quality of Life scale (Skevington, Lotfy, & O'Connell, 2004) . Mindfulness skills and self-compassion were assessed with the Five Facet Mindfulness Questionnaire (Baer et al., 2008 ) and the Self-Compassion Scale (Neff, 2003) , respectively. More information about these secondary outcome measures can be found in the published study protocol (Cladder-Micus et al., 2015, pp. 5-6 ).
Statistical analysis
The power calculation was based on a Cohen's d effect size of 0.53 for currently depressed patients as reported in a previous study (van Aalderen et al., 2011) . Based on an of 0.05 and power of 80%, TA B L E 2 Total number of participants and mean amount of therapy sessions received as treatment-as-usual (TAU) and changes in antidepressant medication from baseline to posttreatment 
RESULTS
Patient flow
Of the 213 patients who were assessed for eligibility, 111 were interviewed and 106 were randomized over MBCT + TAU (n = 49) and TAU (n = 57) (see Figure 1 ). There were no significant differences in clinical characteristics or baseline scores between the conditions (see Table 1 ). Before entering the study, 102 participants had Table 2 in the Supporting Information). No serious adverse events occurred.
Primary outcome
Depression scores were analyzed separately for the ITT sample and the PP sample. In both analyses, the MBCT + TAU condition showed lower levels of depressive symptoms than TAU, with small to medium effect sizes. However, the difference was only significant in the PP sample Table 3 ). Sensitivity analyses using the LOCF sample led to similar findings.
TA B L E 3
When participants who refused to take antidepressant medication (n = 5) were excluded from the analyses, results of the ITT sample (-3.01, 95% CI [-6.8, 0.78] , d = 0.31, P = 0.12) and the PP sample (-4.59, 95% CI [-8.8, -0.38] , d = 0.51, P = 0.03) were comparable to the main analyses.
Secondary outcomes
Compared to TAU, a significantly larger proportion of MBCT + TAU participants reached remission (MBCT + TAU: 41.5%; TAU: 21.6%, Table 4 ). However, most cases were classified as partial remission (MBCT + TAU: 39.0%; TAU: 17.65%) and a minority as full remission Tables 3 and 4) . 
Moderation analyses
DISCUSSION
The aim of the current study was to investigate the effectiveness of MBCT + TAU for chronic, treatment-resistant depressed patients, who
had not improved during not only previous pharmacotherapy but also This study is the first to investigate the effectiveness of MBCT + TAU for chronic, treatment-resistant depressed patients who did not benefit from pharmacotherapy and psychological treatment. The current study has high ecological validity because of its pragmatic design.
Participants were moderately to severely depressed outpatients and were enrolled in MBCT trainings provided regularly at their local mental health care institution. Thereby this study provides much-needed insight into the effectiveness rather than efficacy of MBCT, which was formulated as an important research goal in a recent review paper of MBCT (Dimidjian & Segal, 2015) . However, the effect sizes found Note. Remission is defined as reporting no DSM-IV symptoms of depression during the last 2 weeks based on the MINI. Partial remission is defined as reporting some symptoms but not fulfilling DSM-IV criteria for a major depressive disorder. Depression is defined as fulfilling the DSM-IV criteria for major depression on the MINI.
explained by the higher severity of symptoms in the current study sample compared to previous research (van Aalderen et al., 2011) . As only completers showed a significant decrease in depressive symptoms, obstacles to completing treatment should be investigated in future research, for example, by conducting qualitative interviews.
In addition to the effectiveness of MBCT, we also investigated possible moderators of treatment effect. Importantly, levels of rumination moderated the effect of MBCT + TAU compared to TAU on depressive symptoms. Participants with high levels of rumination benefitted more from MBCT + TAU than TAU. According to the underlying theoretical model, rumination is an important working mechanism of MBCT (Segal et al., 2002) and previous work has indicated that rumination might mediate the effect of MBCT on depressive symptoms (Shahar, Britton, Sbarra, Figueredo, & Bootzin, 2010; van der Velden et al., 2015) . The current study indicates that MBCT could be particularly helpful for chronic, treatment-resistant depressed patients with high levels of rumination. However, because of the explorative nature of the moderation analysis, this finding should be interpreted as preliminary and requires replication and further investigation. In addition, the results of the current study showed no moderating effects of childhood trauma, baseline severity of depression, chronicity, or treatment resistance. Moderating effects of childhood trauma and severity of baseline symptoms were previously found in recurrent depressed patients (Ma & Teasdale, 2004; Williams et al., 2014) . However, recent studies on MBCT in chronic or pharmacoresistant depression found no moderating effect of these variables (Eisendrath et al., 2016; Michalak et al., 2016) , which is in line with our findings. Taken together, these results indicate that rumination might be an important moderator in chronic, treatment-resistant depression, while levels of childhood trauma and severity of depressive symptoms at baseline appear to be of less influence.
A limitation of the current study is that MBCT was implemented as an add-on to TAU. The results in the MBCT + TAU condition could therefore be partially due to nonspecific therapy effects, such as peer support, hope, and attention received from the therapist. Additionally, patients and investigators were not blind to treatment allocation, which might have been a potential source of bias. Future studies should compare MBCT to active treatments matched on treatment intensity and should also investigate long-term effects and cost effectiveness. Furthermore, due to the pragmatic design of the study, MBCT trainings were not in all cases immediately available after randomization. Participants who had to wait more than 4 weeks until the start of MBCT received a second baseline assessment. This means that the total duration of the study is not identical for the conditions.
However, one should note that we found no difference in depressive symptoms between the first and second baseline assessment. In addition, research designs investigating potential mediators such as rumination, mindfulness skills, and self-compassion by including multiple assessments during the course of MBCT would give further insight into mechanisms of change.
The current study provides several clinical and research implica- 
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